CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding CytomX Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 76 | 67 | −9 |
| Shares | 35.5M | 34.1M | −1.42M (−4.0%) |
| Value | $53.7M | $58.7M | +$4.94M (+9.2%) |
New holders (4)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 344,169 | $592.0K | 0.06% |
| Vontobel Holding Ltd. | 10,000 | $17.2K | 0.00% |
| Rhumbline Advisers | 1,291 | $2.22K | 0.00% |
| Simplex Trading, LLC | 709 | $1.00K | 0.00% |
Sold out (13)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Newtyn Management, LLC | 425,000 | $641.8K |
| Tejara Capital Ltd | 157,928 | $238.5K |
| Man Group plc | – | $76.0K |
| Virtu Financial LLC | 24,136 | $36.0K |
| Magnus Financial Group LLC | 20,000 | $30.2K |
| XTX Topco Ltd | 17,815 | $26.9K |
| Cetera Investment Advisers | 15,000 | $22.6K |
| Qube Research & Technologies Ltd | 13,050 | $19.7K |
| Two Sigma Securities, LLC | 10,808 | $16.3K |
| Beacon Capital Management, LLC | 5,000 | $7.55K |
| FNY Investment Advisers, LLC | 4,500 | $6.00K |
| Advisory Services Network, LLC | 412 | $622 |
| IFP Advisors, Inc | 222 | – |